Rosenbloom AL. The physiology of human growth: a review. Reviews in Endocrinology. July 2008. 36-48.
Rosenbloom AL. Recombinant insulin growth factor I in growth therapy. Preedy VR (ed). Handbook of Growth and Growth Monitoring in Health and Disease Springer. New York: Verlag; 2012. 2743-62.
Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996 Oct 31. 335(18):1363-7. [QxMD MEDLINE Link].
Walenkamp MJ, Karperien M, Pereira AM, et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab. 2005 May. 90(5):2855-64. [QxMD MEDLINE Link].
Bonapace G, Concolino D, Formicola S, Strisciuglio P. A novel mutation in a patient with insulin-like growth factor 1(IGF1) deficiency. J Med Genet. 2003. 40:913–7.
Netchine I, Azzi S, Houang M, Seurin D, Perin L, Ricort JM. Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J Clin Endocrinol Metab. 2009 Oct. 94(10):3913-21. [QxMD MEDLINE Link].
Abuzzahab MJ, Schneider A, Goddard A, et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med. 2003 Dec 4. 349(23):2211-22. [QxMD MEDLINE Link].
Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Francke U. Growth hormone receptor deficiency in Ecuador. J Clin Endocrinol Metab. 1999 Dec. 84(12):4436-43. [QxMD MEDLINE Link].
Laron Z, Kopchick JJ. History of Israeli cohort of Laron syndrome patients (1958-2009). Laron syndrome-from Man to Mouse. Berlin-Heidelberg: Springer-Verlag; 2011. 3-7.
Kranzler JH, Rosenbloom AL, Martinez V, Guevara-Aguirre J. Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population. J Clin Endocrinol Metab. 1998 Jun. 83(6):1953-8. [QxMD MEDLINE Link].
Nadeau K, Hwa V, Rosenfeld RG. STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr. 2011 May. 158(5):701-8. [QxMD MEDLINE Link].
Goncalves FT, Fridman C, Pinto EM, et al. The E180Splice mutation in the GHR gene causing Laron Syndrome: Witness of a Sephardic Jewish exodus from the Iberian Peninsula to the New World?. Am J Med Genet. 2014. Part A 9999:1-5. [QxMD MEDLINE Link].
Domene HM, Bengolea SV, Martinez AS, et al. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Engl J Med. 2004 Feb 5. 350(6):570-7. [QxMD MEDLINE Link].
Hwa V, Haeusler G, Pratt KL, et al. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure. J Clin Endocrinol Metab. 2006 May. 91(5):1826-31. [QxMD MEDLINE Link].
Domene HM, Scaglia PA, Lteif A, et al. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations. J Clin Endocrinol Metab. 2007 Nov. 92(11):4444-50. [QxMD MEDLINE Link].
Heath KE, Argente J, Barrios V, et al. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia. J Clin Endocrinol Metab. 2008 May. 93(5):1616-24. [QxMD MEDLINE Link].
van Duyvenvoorde HA, Kempers MJ, Twickler TB, et al. Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit. Eur J Endocrinol. 2008 Aug. 159(2):113-20. [QxMD MEDLINE Link].
Fofanova-Gambetti OV, Hwa V, Kirsch S, et al. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins. Horm Res. 2009. 71(2):100-10. [QxMD MEDLINE Link].
Fofanova-Gambetti OV, Hwa V, Wit JM, Domene HM, Argente J, Bang P. Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature: results from the international acid-labile subunit consortium. J Clin Endocrinol Metab. 2010 Sep. 95(9):4184-91. [QxMD MEDLINE Link].
Kawashima Y, Kanzaki S, Yang F, et al. Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. J Clin Endocrinol Metab. 2005 Aug. 90(8):4679-87. [QxMD MEDLINE Link].
Walenkamp MJ, van der Kamp HJ, Pereira AM, et al. A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab. 2006 Aug. 91(8):3062-70. [QxMD MEDLINE Link].
Inagaki K, Tiulpakov A, Rubtsov P, et al. A familial insulin-like growth factor-I receptor mutant leads to short stature: clinical and biochemical characterization. J Clin Endocrinol Metab. 2007 Apr. 92(4):1542-8. [QxMD MEDLINE Link].
Walenkamp MJ, de Muinck Keizer-Schrama SM, de Mos M, et al. Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification. J Clin Endocrinol Metab. 2008 Jun. 93(6):2421-5. [QxMD MEDLINE Link].
Fang P, Schwartz ID, Johnson BD, et al. Familial short stature caused by haploinsufficiency of the insulin-like growth factor i receptor due to nonsense-mediated messenger ribonucleic acid decay. J Clin Endocrinol Metab. 2009 May. 94(5):1740-7. [QxMD MEDLINE Link].
Kruis T, Klammt J, Galli-Tsinopoulou A, Wallborn T, Schlicke M, Muller E. Heterozygous mutation within a kinase-conserved motif of the insulin-like growth factor I receptor causes intrauterine and postnatal growth retardation. J Clin Endocrinol Metab. 2010 Mar. 95(3):1137-42. [QxMD MEDLINE Link].
Wallborn T, Wuller S, Klammt J, Kruis T, Kratzsch J, Schmidt G. A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplasmic reticulum and results in intrauterine and postnatal growth retardation. J Clin Endocrinol Metab. 2010 May. 95(5):2316-24. [QxMD MEDLINE Link].
Choi JH, Kang M, Kim GH, et al. Clinical and functional characteristics of a novel heterozygous mutation of the IGF1R gene and IGF1R haploinsufficiency due to terminal 15q26.2->qter deletion in patients with intrauterine growth retardation and postnatal catch-up growth failure. J Clin Endocrinol Metab. 2011 Jan. 96(1):E130-4. [QxMD MEDLINE Link].
Fang P, Cho YH, Derr MA, Rosenfeld RG, Hwa V, Cowell CT. Severe short stature caused by novel compound heterozygous mutations of the insulin-like growth factor 1 receptor (IGF1R). J Clin Endocrinol Metab. 2012 Feb. 97(2):E243-7. [QxMD MEDLINE Link].
Mohn A, Marcovecchio ML, de Giorgis T, Pfaeffle R, Chiarelli F, Kiess W. An insulin-like growth factor-I receptor defect associated with short stature and impaired carbohydrate homeostasis in an Italian pedigree. Horm Res Paediatr. 2011. 76(2):136-43. [QxMD MEDLINE Link].
Kawashima Y, Higaki K, Fukushima T, et al. Novel missense mutation in the IGF-I receptor L2 domain results in intrauterine and postnatal growth retardation. Clin Endocrinol (Oxf). 2012 Aug. 77(2):246-54. [QxMD MEDLINE Link].
Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism?. Isr J Med Sci. 1966 Mar-Apr. 2(2):152-5. [QxMD MEDLINE Link].
Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Diamond FB Jr, Rosenfeld RG. Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. J Clin Endocrinol Metab. 1993 Feb. 76(2):417-23. [QxMD MEDLINE Link].
Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011 Feb 16. 3(70):70ra13. [QxMD MEDLINE Link]. [Full Text].
Gannage-Yared MH, Klammt J, Chouery E, et al. Homozygous mutation of the IGF1 receptor gene in a patient with severe pre- and postnatal growth failure and congenital malformations. Eur J Endocrinol. 2013 Jan. 168(1):K1-7. [QxMD MEDLINE Link].
Rosenbloom AL, Guevara-Aguirre J. Lessons from the genetics of laron syndrome. Trends Endocrinol Metab. 1998 Sep. 9(7):276-83. [QxMD MEDLINE Link].
Ayling RM, Ross R, Towner P, et al. A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet. 1997 May. 16(1):13-4. [QxMD MEDLINE Link].
Iida K, Takahashi Y, Kaji H, et al. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain. J Clin Endocrinol Metab. 1998 Feb. 83(2):531-7. [QxMD MEDLINE Link].
Metherell LA, Akker SA, Munroe PB, et al. Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity. Am J Hum Genet. 2001 Sep. 69(3):641-6. [QxMD MEDLINE Link]. [Full Text].
Crosnier H, Gourmelen M, Prevot C, Rappaport R. Effects of nutrient intake on growth, insulin-like growth factors, and their binding proteins in a Laron-type dwarf. J Clin Endocrinol Metab. 1993 Jan. 76(1):248-50. [QxMD MEDLINE Link].
Guevara-Aguirre J, Vasconez O, Martinez V, et al. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab. 1995 Apr. 80(4):1393-8. [QxMD MEDLINE Link].
Rosenbloom AL. Mecasermin (recombinant human insulin-like growth factor I). Adv Ther. 2009 Jan. 26(1):40-54. [QxMD MEDLINE Link].
Ekstrom K, Carlsson-Skwirut C, Ritzen EM, Bang P. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 cotreatment versus insulin-like growth factor-I alone in two brothers with growth hormone insensitivity syndrome: effects on insulin sensitivity, body composition and linear growth. Horm Res Paediatr. 2011. 76(5):355-66. [QxMD MEDLINE Link].
Guevara-Aguirre J, Rosenbloom AL, Vasconez O, et al. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. J Clin Endocrinol Metab. 1997 Feb. 82(2):629-33. [QxMD MEDLINE Link].
Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 1989 Feb. 10(1):68-91. [QxMD MEDLINE Link].
Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Wilton P. Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes. Horm Res. 1999. 51(3):128-34. [QxMD MEDLINE Link].
Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab. 2007 Mar. 92(3):902-10. [QxMD MEDLINE Link].
Klinger B, Laron Z. Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab. 1995 Jul-Sep. 8(3):149-58. [QxMD MEDLINE Link].
Guevara-Aguirre J, Rosenbloom AL, Guevara-Aguirre M, Saavedra J, Procel P. Recommended IGF-I dosage causes greater fat accumulation and osseous maturation than lower dosage and may compromise long-term growth effects. J Clin Endocrinol Metab. 2013 Feb. 98(2):839-45. [QxMD MEDLINE Link].
Rosenbloom AL, Rivkees SA. Off-label use of recombinant igf-I to promote growth: is it appropriate?. J Clin Endocrinol Metab. 2010 Feb. 95(2):505-8. [QxMD MEDLINE Link].
Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 2007 Feb. 28(1):20-47. [QxMD MEDLINE Link].
Perry JK, Emerald BS, Mertani HC, Lobie PE. The oncogenic potential of growth hormone. Growth Horm IGF Res. 2006 Oct-Dec. 16(5-6):277-89. [QxMD MEDLINE Link].
Guevara-Aguirre J, Rosenbloom AL, Balasubramanian P, et al. GH receptor deficiency in Ecuadorian adults is associated with obesity and enhanced insulin sensitivity. J Clin Endocrinol Metab. 2015 Jul. 100(7):2589-96. [QxMD MEDLINE Link]. [Full Text].
Rosenbloom AL. Genetic disorders of the hypothalamic-pituitary-GH/IGF-I axis. Preedy VR, ed. Handbook of Growth and Growth Monitoring in Health and Disease. New York: Springer-Verlag; 2012. 2723-41.
Forrest L, Sedmak C, Sikder S, et al. Effects of growth hormone on hepatic insulin sensitivity and glucose effectiveness in healthy older adults. Endocrine. 2019 Jan 7. [QxMD MEDLINE Link].
Boguszewski CL, Barbosa EJL, Svensson PA, Johannsson G, Glad CAM. Mechanisms in Endocrinology: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism. Eur J Endocrinol. 2017 Dec. 177(6):R309-R321. [QxMD MEDLINE Link]. [Full Text].
Kurtoglu S, Hatipoglu N. Growth hormone insensitivity: diagnostic and therapeutic approaches. J Endocrinol Invest. 2016 Jan. 39(1):19-28. [QxMD MEDLINE Link].
Gentilin E, Minoia M, Bondanelli M, et al. Growth hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines. Endocrine. 2017 Jun. 56(3):621-32. [QxMD MEDLINE Link].